LeMaitre Q2 2026 Financial Results
LeMaitre Vascular, a Nasdaq-listed medical device provider, posted Q2 2026 sales of $70.4 million, a 10% increase over the prior year driven by strong growth in their Artegraft product internationally. Operating income rose 26%, with gross margin expanding by 210 basis points. The company declared a quarterly dividend of $0.25 per share and reaffir…